Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Alterity Therapeutics (NASDAQ:ATHE) through any online brokerage.
Other companies in Alterity Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Alterity Therapeutics has a consensus price target of $10.80.
The stock price for Alterity Therapeutics (NASDAQ: ATHE) is $4.6 last updated August 20, 2026 at 9:27 AM EDT.
There are no upcoming dividends for Alterity Therapeutics.
Alterity Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Alterity Therapeutics.
Alterity Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.